BR112017004630A2 - composição prebiótica sinérgica - Google Patents

composição prebiótica sinérgica

Info

Publication number
BR112017004630A2
BR112017004630A2 BR112017004630A BR112017004630A BR112017004630A2 BR 112017004630 A2 BR112017004630 A2 BR 112017004630A2 BR 112017004630 A BR112017004630 A BR 112017004630A BR 112017004630 A BR112017004630 A BR 112017004630A BR 112017004630 A2 BR112017004630 A2 BR 112017004630A2
Authority
BR
Brazil
Prior art keywords
prebiotic
present
prebiotic composition
synergistic
compositions
Prior art date
Application number
BR112017004630A
Other languages
English (en)
Other versions
BR112017004630B1 (pt
Inventor
Lynn Vanden Heuvel Amy
Mae Uttecht Cathleen
Andrew Moline David
William Koenig David
Janne Johnson Jeffrey
Caroline Rogers Jessica
Andrew Zawadzki Michael
Ann Vongsa Rebecca
Park Sangha
Kim Youngsook
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR112017004630A2 publication Critical patent/BR112017004630A2/pt
Publication of BR112017004630B1 publication Critical patent/BR112017004630B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)

Abstract

a presente invenção refere-se às composições e formulações prebióticas compreendendo um a-hidroxiácido e sais do mesmo, tais como ácido lático, glicólico, cítrico, tartárico ou málico e um agente prebiótico, tal como inulina, frutooligossacarídeo (fos), lactulose, galactooligossacarídeo (gos), rafinose, estaquiose, isomaltooligossacarídeo e xilooligossacarídeo. as composições prebióticas da presente invenção proporcionam um efeito prebiótico surpreendentemente sinérgico e podem ser administradas de várias formas a um usuário, tal como pela aplicação em um substrato de limpeza pré-umedecido ou papel higiênico seco.
BR112017004630-0A 2014-09-30 2014-09-30 Formulação prebiótica sinérgica, lenço prebiótico, e, lenço umedecido prebiótico BR112017004630B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/058369 WO2016053308A1 (en) 2014-09-30 2014-09-30 Synergistic prebiotic composition

Publications (2)

Publication Number Publication Date
BR112017004630A2 true BR112017004630A2 (pt) 2018-01-30
BR112017004630B1 BR112017004630B1 (pt) 2023-04-11

Family

ID=55631163

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017004630-0A BR112017004630B1 (pt) 2014-09-30 2014-09-30 Formulação prebiótica sinérgica, lenço prebiótico, e, lenço umedecido prebiótico

Country Status (9)

Country Link
US (1) US10441603B2 (pt)
EP (1) EP3200766B1 (pt)
KR (1) KR20170065540A (pt)
CN (1) CN107072941B (pt)
AU (1) AU2014407509B2 (pt)
BR (1) BR112017004630B1 (pt)
CO (1) CO2017003280A2 (pt)
MX (1) MX2017003293A (pt)
WO (1) WO2016053308A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2636621C1 (ru) * 2016-08-08 2017-11-24 Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" Препарат-пребиотик для овец
US20220347294A1 (en) * 2019-09-23 2022-11-03 The Regents Of The University Of Michigan Compositions and methods for increasing the efficacy of immunotherapies and vaccines
US20220233559A1 (en) * 2021-01-27 2022-07-28 Prenexus Health, Inc. Xylooligosaccharide as a multifunctional prebiotic

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2738652C3 (de) 1977-08-26 1981-02-19 Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US7144173B2 (en) * 1998-11-09 2006-12-05 The Procter & Gamble Company Cleaning composition, pad, wipe, implement, and system and method of use thereof
US20030185811A1 (en) 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
EP1530479A2 (de) 2002-08-16 2005-05-18 Finzelberg GmbH & Co. KG Arznei-, nahrungsergänzungsmittel und futtermittelzusatz
EP1471070A1 (en) 2003-04-22 2004-10-27 Royal Schouten Group N.V. Method for recovering a secondary plant metabolite
WO2005021575A2 (en) 2003-08-29 2005-03-10 Gregor Reid Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
US20050112239A1 (en) * 2003-11-20 2005-05-26 Rudin Richard E. Instant yogurt food product
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
JP2007533755A (ja) 2004-04-20 2007-11-22 ザ ユニヴァーシティ オヴ シカゴ 高分子量ｐｅｇ様化合物を含む治療薬送達システム
US8110215B2 (en) 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
EP1600062A1 (en) 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and sterols
US7642395B2 (en) 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
EP1736537A1 (en) 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP2009506056A (ja) 2005-08-22 2009-02-12 クイック−メッド テクノロジーズ、インク． 基質の表面に抗菌カチオン性多価電解質を付着する方法
US8444811B2 (en) * 2005-12-15 2013-05-21 Kimberly-Clark Worldwide, Inc. Process for increasing the basis weight of sheet materials
CN105360562A (zh) 2006-04-21 2016-03-02 洲际大品牌有限责任公司 包衣组合物、糖食和咀嚼型胶基糖组合物以及方法
GB0724550D0 (en) 2007-12-18 2008-01-30 Univ Hull Formulations
IT1392672B1 (it) * 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
WO2010123419A1 (en) 2009-04-20 2010-10-28 Sca Hygiene Products Ab Packaged wipe or hygiene tissue
BR112012010272A2 (pt) 2009-10-30 2019-10-01 Biogenic Innovations Llc métodos de aumento da eficiência de fermentação de um micro-organismo, in vitro para aumento do crescimento de um ou mais micro-organismos probióticos, para aumento do crescimento de um micro-organismo em uma amostra de teste de diagnóstico e de inibição de atividade microbiana ex vivo, e uso de metilsulfonilmetano (msm)
JP6006117B2 (ja) 2009-11-12 2016-10-12 ネステク ソシエテ アノニム 腸内微生物叢バランス及び健康を促進するための栄養組成物
JP6028264B2 (ja) 2010-03-12 2016-11-16 ディーエスエム アイピー アセッツ ビー．ブイ． 母体へのシアル酸補給
US20120035277A1 (en) 2010-08-04 2012-02-09 Hero Nutritionals, LLC Liquid-filled chewable supplement
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
US8552251B2 (en) 2010-10-08 2013-10-08 Kimberly-Clark Worldwide, Inc. Article with health-benefit agent delivery system
US9259019B2 (en) 2010-11-11 2016-02-16 Mars, Incorporated Bifidobacteriumstrain
US8916012B2 (en) 2010-12-28 2014-12-23 Kimberly-Clark Worldwide, Inc. Method of making substrates comprising frothed benefit agents
US8506978B2 (en) 2010-12-28 2013-08-13 Kimberly-Clark Worldwide, Inc. Bacteriostatic tissue product
JP2014506923A (ja) 2011-03-01 2014-03-20 クオラム イノベーションズ リミテッド ライアビリティ カンパニー 病原性バイオフィルムと関連した状態を治療するための物質および方法
GB2495491A (en) 2011-05-23 2013-04-17 Bio4 Ltd Pre-biotic skin wipe
CN102370598A (zh) * 2011-09-30 2012-03-14 天津市中科健新材料技术有限公司 一种用于湿巾的益生元香体整理液
CN104245356A (zh) * 2012-02-29 2014-12-24 株式会社普利司通 轮胎
JP6010310B2 (ja) * 2012-03-05 2016-10-19 Ｋｙｂ株式会社 ロータリダンパ
EP2656862A1 (en) 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
US9243367B2 (en) 2012-10-05 2016-01-26 Kimberly-Clark Worldwide, Inc. Soft creped tissue
CN102871921A (zh) * 2012-10-15 2013-01-16 金红叶纸业集团有限公司 洗手剂组合物
CN103768651A (zh) * 2012-10-17 2014-05-07 天津市中科健新材料技术有限公司 一种应用于婴儿纸尿裤的益生元粉体
CN103110665B (zh) * 2013-01-24 2015-12-02 量子高科(中国)生物股份有限公司 一种维护生殖道微生态屏障的组合物及其应用
WO2015031105A1 (en) 2013-08-28 2015-03-05 The Procter & Gamble Company Substrate comprising oligogalacturonides and disposable absorbent article comprising the substrate
US20150209468A1 (en) 2014-01-24 2015-07-30 The Procter & Gamble Company Hygiene article containing microorganism
BR112017004118B1 (pt) 2014-09-30 2022-04-12 Kimberly-Clark Worldwide, Inc Trama de papel crepado, produto de papel crepado de múltiplas camadas, e, método de fabricação de uma trama de papel crepado prebiótico

Also Published As

Publication number Publication date
WO2016053308A1 (en) 2016-04-07
EP3200766A1 (en) 2017-08-09
US20170258823A1 (en) 2017-09-14
CN107072941A (zh) 2017-08-18
CN107072941B (zh) 2020-10-13
EP3200766B1 (en) 2019-07-03
EP3200766A4 (en) 2018-06-06
CO2017003280A2 (es) 2017-07-11
BR112017004630B1 (pt) 2023-04-11
AU2014407509A1 (en) 2017-04-13
KR20170065540A (ko) 2017-06-13
US10441603B2 (en) 2019-10-15
MX2017003293A (es) 2017-06-21
AU2014407509B2 (en) 2020-09-03

Similar Documents

Publication Publication Date Title
CY1124486T1 (el) Υποκατεστημενα βενζαμιδια 1,3-θειαζολ-2-υλιου
MX2016006221A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
PH12016501807A1 (en) Novel compounds
TN2015000371A1 (en) Substituted imidazopyridazines
BR112017010868A2 (pt) composição adoçante
PH12017550039A1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
MX339413B (es) Composiciones liquidas de limpieza y desinfeccion.
MX2017014843A (es) Sistema de agente tensoactivo eficiente en plastico y todo tipo de articulos.
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
PL3046948T3 (pl) Modyfikowane kwasy poliasparaginowe, ich wytwarzanie i ich zastosowanie jako dyspergatorów i środków zapobiegających powstawaniu osadów w kompozycjach środków do prania, zmywania i czyszczenia oraz w uzdatnianiu wody
BR112017004630A2 (pt) composição prebiótica sinérgica
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
CL2018002897A1 (es) Sistemas de formulación para glicolípidos antimicrobianos.
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
MX365973B (es) Barras de limpieza con taurina.
PE20170510A1 (es) Composicion prebiotica sinergica
MX2016014261A (es) Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis.
AR111666A1 (es) Composiciones tópicas que tienen por objeto mantener y restaurar la homeostasis del agua de la piel
MX2018006526A (es) Barras de limpieza con taurina.
MA39762A (fr) Nouveaux composés
NZ764041A (en) Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis
TN2014000091A1 (en) Amino-substituted imidazopyridazines
TH158883B (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือการรักษาโรคลำไส้อักเสบชนิดเนื้อตาย ในทารกและเด็กเล็ก

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/09/2014, OBSERVADAS AS CONDICOES LEGAIS